Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 25 to 80

Minimally invasive artery embolization for chronic Achilles tendon pain

Official title: Achilles Tendinopathy Embolization (ATE) With LipioJoint: An Early Feasibility Study

Run by Joint & Vascular Institute · NCT07477860 · Data updated 2026-11-12

This trial will try injecting a temporary Lipiodol emulsion into blood vessels feeding the Achilles tendon to reduce chronic tendon pain in adults 25 to 80 who haven't improved after conservative treatment.

More Achilles Tendinopathy trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages25 Years to 80 Years
SexAll
Enrollment10 (estimated)
SponsorJoint & Vascular Institute
Industry-sponsored
Locations1 site (Libertyville, Illinois)
StatusRecruiting
StartedApril 1, 2026
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedApril 23, 2026
Trial IDNCT07477860 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25–80 with chronic Achilles tendinopathy resistant to at least three months of conservative care, reporting at least 4/10 pain on the VAS and who prefer to avoid surgery are the intended participants.

Probably not a fit

People with acute fracture/trauma, inflammatory tendon disease, recent steroid injection (within 90 days), peripheral arterial disease, severe contrast allergy, impaired kidney function (GFR <45 or creatinine >2.0 mg/dL), type 1 diabetes, pregnancy/breastfeeding, anticoagulation or irreversible coagulopathy, or tendon rupture are excluded and unlikely to benefit from this procedure.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants undergo a minimally invasive catheter procedure in which a radiologist injects a temporary blocking agent (LipioJoint/Lipiodol emulsion) into specific arteries supplying the affected Achilles tendon. Pain intensity will be measured using the Visual Analog Scale (VAS) at baseline and at 1, 3, 6, and 12 months after the procedure, with a phone check one day after treatment to screen for early side effects. The study is a Phase 1 interventional trial focused on feasibility and safety, tracking serious adverse events related to the device and procedure over 12 months. The goal is to determine whether the procedure can safely and durably reduce chronic Achilles pain in adults who are non-surgical candidates or wish to avoid surgery.

Why it matters

Potential benefit: If successful, this procedure could reduce chronic Achilles tendon pain and offer a less invasive alternative to surgery.

How similar studies have gone: Early case series and small observational studies of arterial embolization for tendinopathies have reported promising pain reductions, but larger controlled trials are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 25 years
* Subject provides written informed consent
* Patient with Achilles tendinopathy refractory to 3 months of conservative management
* Self reported pain of at least 4/10 on visual analog scale (VAS)
* Non-surgical candidate/looking to avoid surgery

Exclusion Criteria:

* Achilles tendon pain caused by acute fracture, recent trauma, inflammatory conditions, muscle/ligament injury, tendon rupture, and etiologies related to bone mineral density
* Steroid injection in the last 90 days from the embolization procedure
* Known severe allergy to Lipiodol and/or iodinated contrast media
* Diagnosis of peripheral arterial disease affecting the lower extremities
* Pregnancy or breastfeeding
* Anticoagulation or irreversible coagulopathy
* GFR \<45 or Serum creatinine \> 2.0 mg/dl
* Type 1 Diabetes Mellitus

Where it's running

  • Joint and Vascular Institute
    Libertyville, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.